ATE200493T1 - Verbesserte chimäre toxine - Google Patents

Verbesserte chimäre toxine

Info

Publication number
ATE200493T1
ATE200493T1 AT91906038T AT91906038T ATE200493T1 AT E200493 T1 ATE200493 T1 AT E200493T1 AT 91906038 T AT91906038 T AT 91906038T AT 91906038 T AT91906038 T AT 91906038T AT E200493 T1 ATE200493 T1 AT E200493T1
Authority
AT
Austria
Prior art keywords
fragment
toxin
diphtheria toxin
chimeric
domain
Prior art date
Application number
AT91906038T
Other languages
English (en)
Inventor
Diane Williams
John R Murphy
Original Assignee
Boston Medical Ct Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27049417&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE200493(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boston Medical Ct Corp filed Critical Boston Medical Ct Corp
Application granted granted Critical
Publication of ATE200493T1 publication Critical patent/ATE200493T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Detergent Compositions (AREA)
AT91906038T 1990-03-02 1991-02-28 Verbesserte chimäre toxine ATE200493T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48860890A 1990-03-02 1990-03-02
US53743090A 1990-06-13 1990-06-13
PCT/US1991/001282 WO1991013090A1 (en) 1990-03-02 1991-02-28 Improved chimeric toxins

Publications (1)

Publication Number Publication Date
ATE200493T1 true ATE200493T1 (de) 2001-04-15

Family

ID=27049417

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91906038T ATE200493T1 (de) 1990-03-02 1991-02-28 Verbesserte chimäre toxine

Country Status (11)

Country Link
US (6) US5616482A (de)
EP (1) EP0517829B2 (de)
JP (1) JP3311346B2 (de)
AT (1) ATE200493T1 (de)
CA (1) CA2076678C (de)
DE (1) DE69132581T3 (de)
DK (1) DK0517829T4 (de)
ES (1) ES2155821T5 (de)
FI (1) FI923915L (de)
GR (1) GR3036081T3 (de)
WO (1) WO1991013090A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214787B1 (en) * 1993-09-21 2007-05-08 United States Of America As Represented By The Secretary Of The Army Recombinant vaccine against botulinum neurotoxin
US6737511B1 (en) * 1999-08-16 2004-05-18 The United States Of America As Represented By The Department Of Health And Human Services Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis
US20030162733A1 (en) * 2000-11-27 2003-08-28 Haynes Joel R. Nucleic acid adjuvants
US7273722B2 (en) 2000-11-29 2007-09-25 Allergan, Inc. Neurotoxins with enhanced target specificity
US7585942B2 (en) * 2003-11-25 2009-09-08 Anjin Corporation Diphtheria toxin variant
BRPI0509469A (pt) * 2004-03-31 2007-09-11 Trophogen Inc superagonistas do hormÈnio glicoprotéico humano e uso dos mesmos
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
AU2007291943B2 (en) * 2006-08-28 2013-11-14 Clinuvel Pharmaceuticals Limited Method for reducing incidence or rate of development of skin cancers and related conditions
ES2781402T7 (es) 2006-09-07 2021-06-09 Scott & White Memorial Hospital Métodos y composiciones basadas en conjugados de toxina diftérica-interleucina-3
WO2008157776A2 (en) * 2007-06-21 2008-12-24 Angelica Therapeutics, Inc. Modified diphtheria toxins
WO2009110944A1 (en) * 2008-02-29 2009-09-11 Angelica Therapeutics, Inc. Modified toxins
US9321820B2 (en) * 2009-10-14 2016-04-26 The Regents Of The University Of Colorado Compositions and methods for treating bladder cancer
HK1220376A1 (zh) 2013-03-15 2017-05-05 Angelica Therapeutics, Inc. 修饰的毒素
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11203626B2 (en) 2016-03-10 2021-12-21 The Johns Hopkins University Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
US11965009B2 (en) 2016-03-10 2024-04-23 The Johns Hopkins University Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
WO2017156356A1 (en) 2016-03-10 2017-09-14 The Johns Hopkins University Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
EP4204008A1 (de) 2020-08-26 2023-07-05 Citius Pharmaceuticals, Inc. Kombination zur verwendung in verfahren zur behandlung von krebs

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3369466D1 (en) 1982-05-12 1987-03-05 Harvard College Fused genes encoding hybrid proteins, cloning vectors containing them and the use thereof
US4468382A (en) † 1982-07-15 1984-08-28 New England Medical Center, Inc. Polypeptide-toxin hybrid protein
US4830962A (en) * 1984-02-09 1989-05-16 Cetus Corporation Recombinant diphtheria toxin fragments
EP0170697B1 (de) * 1984-02-08 1991-10-23 Cetus Oncology Corporation Toxinkonjugate
ES8708014A1 (es) * 1984-06-07 1987-09-01 Murphy John R Un procedimiento para preparar un gen fusionado que codifica una proteina hibrida susceptible de marcado y empleo en diagnosis.
EP0246307B1 (de) * 1985-11-13 1994-02-02 University Hospital The Durch cys-kodon modifizierte dns
IN165717B (de) * 1986-08-07 1989-12-23 Battelle Memorial Institute
IL89504A0 (en) * 1988-03-08 1989-09-10 Univ Wyoming Diphtheria toxin derivative,process for the preparation thereof and pharmaceutical composition containing the same
JPH06503553A (ja) * 1990-06-13 1994-04-21 ザ・ユニバーシティ・ホスピタル 改良されたドメイン間幾何を有するキメラ毒素類

Also Published As

Publication number Publication date
US5616482A (en) 1997-04-01
ES2155821T5 (es) 2008-04-16
US5763250A (en) 1998-06-09
FI923915A0 (fi) 1992-09-01
DE69132581T2 (de) 2002-04-11
DK0517829T4 (da) 2008-03-03
EP0517829A1 (de) 1992-12-16
GR3036081T3 (en) 2001-09-28
AU661819B2 (en) 1995-08-10
FI923915A7 (fi) 1992-09-01
CA2076678A1 (en) 1991-09-03
AU7493191A (en) 1991-09-18
JPH06500531A (ja) 1994-01-20
EP0517829B1 (de) 2001-04-11
JP3311346B2 (ja) 2002-08-05
US5863891A (en) 1999-01-26
DE69132581D1 (de) 2001-05-17
WO1991013090A1 (en) 1991-09-05
DK0517829T3 (da) 2001-05-07
ES2155821T3 (es) 2001-06-01
US5703039A (en) 1997-12-30
US5932471A (en) 1999-08-03
EP0517829B2 (de) 2007-12-26
DE69132581T3 (de) 2008-07-17
CA2076678C (en) 1999-09-28
US5677148A (en) 1997-10-14
EP0517829A4 (en) 1993-05-05
FI923915L (fi) 1992-09-01

Similar Documents

Publication Publication Date Title
ATE200493T1 (de) Verbesserte chimäre toxine
NO840089L (no) Hybrid-proteiner
KR970702917A (ko) Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체
ATE329033T1 (de) Hybride toxine
NZ504752A (en) Hydrophobically-modified protein compositions (particularly hedgehog proteins)
NZ212312A (en) Hybrid protein comprising fragments of diphtheria toxin and part of cell-specific ligand; and fused gene therefor
Graf et al. Cathepsin D generates γ-endorphin from β-endorphin
Fawell et al. Androgen-regulated proteins of rat seminal vesicle secretion constitute a structurally related family present in the copulatory plug
SE8204811L (sv) Dna-fragment innefattande en signalsekvens
FR2736916B1 (fr) Proteines hetero-multimeriques recombinantes du type alpha-beta c4bp
AR018045A1 (es) Proteina placentaria 13 y polipetido, molecula de adn que los codifica, anticuerpos capaces de enlazarse a ellos, metodo para la deteccion decomplicaciones relacionadas con el embarazo, metodo recombinante para la produccion de dicha proteina y un equipo para el diagnostico de complicacionesrelacion
NO923415L (no) Forbedrede chimere toksiner
DK1355655T3 (da) Præparater og fremgangsmåder til forbedring af nyrefunktion
Greenfield et al. Toxin conjugates.
GB2333295A (en) Modified protein G and fragments thereof
HUP0001462A2 (en) Human toll-like receptor proteins, related reagents and methods

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification

Ref document number: 0517829

Country of ref document: EP

EELA Cancelled due to lapse of time